Lisinopril and Hydrochlorothiazide
- Product NDC
- 68071-4981
- 11-digit product format
- 680714981
- Labeler code
- 68071
- Product ID
- 68071-4981_bbb2e2d4-f3f4-6f1b-e053-2a95a90ae970
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2003-03-04
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4981-3 | 68071498103 | 30 TABLET in 1 BOTTLE (68071-4981-3) | 30 tablet | 2019-07-23 | 0000-00-00 | No | No | Current |